Lord, Abbett & Co’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22M Buy
397,714
+256,505
+182% +$12.2M 0.07% 262
2025
Q4
$5.28M Buy
141,209
+4,945
+4% +$201K 0.02% 457
2025
Q3
$5.51M Buy
+136,264
New +$4.5M 0.02% 453

Other funds holding PAHC

Lord, Abbett & Co's PAHC Position: Q1 2026 in Review

Lord, Abbett & Co increased its Phibro Animal Health (PAHC) stake by 182% in Q1 2026, buying an estimated $12.2M and bringing the position to 397,714 shares worth $22M. The position accounts for 0.07% of the portfolio, ranked #262.

Lord, Abbett & Co first reported a position in PAHC in Q3 2025 and has held it in 3 quarters since. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Lord, Abbett & Co held 397,714 shares of Phibro Animal Health worth $22M as of Q1 2026.
  • Lord, Abbett & Co bought 256,505 Phibro Animal Health shares in Q1 2026, an estimated $12.2M.
  • Phibro Animal Health made up 0.07% of Lord, Abbett & Co's portfolio in Q1 2026, its #262 holding.
  • Lord, Abbett & Co first reported a position in Phibro Animal Health in Q3 2025 and has held it in 3 quarters since.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Lord, Abbett & Co's 13F filing for Q1 2026, filed 14 May 2026.